Description

1H-Imidazo[4,5-C]Pyridine, 5-Acetyl-4-[3-(Acetyloxy)-5-[(Acetyloxy)Methyl]-2-Methyl-4-Pyridinyl]-4,5,6,7-Tetrahydro- (9Ci) is a high-purity, complex heterocyclic compound that serves as a critical advanced pharmaceutical intermediate and building block for sophisticated organic synthesis. Its intricate fused-ring structure makes it a valuable scaffold for developing novel active pharmaceutical ingredients (APIs) and fine chemicals. This compound is primarily utilized by research institutions and pharmaceutical manufacturers engaged in medicinal chemistry and process development.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly those targeting neurological and oncological pathways.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and library synthesis in drug discovery programs.
• Organic Synthesis Building Block: Employed in complex multi-step syntheses to construct more elaborate heterocyclic systems.
• Biochemical Research: Potential use as a probe or inhibitor in enzymatic studies due to its nitrogen-rich aromatic structure.
• Fine Chemical Production: Serves as a specialized intermediate in the manufacture of high-value, low-volume performance chemicals.

Basic Information

Item	Details
Product Name	1H-Imidazo[4,5-C]Pyridine, 5-Acetyl-4-[3-(Acetyloxy)-5-[(Acetyloxy)Methyl]-2-Methyl-4-Pyridinyl]-4,5,6,7-Tetrahydro- (9Ci)
CAS No.	34594-38-2
Molecular Formula	C20H23N3O5
Molecular Weight	385.41 g/mol
Synonyms	5-Acetyl-4-[3-(acetyloxy)-5-[(acetyloxy)methyl]-2-methyl-4-pyridinyl]-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine; 4,5,6,7-Tetrahydro-5-acetyl-4-[3-(acetyloxy)-5-[(acetyloxy)methyl]-2-methyl-4-pyridinyl]-1H-imidazo[4,5-c]pyridine; 1H-Imidazo[4,5-c]pyridine, 4,5,6,7-tetrahydro-5-acetyl-4-[3-(acetyloxy)-5-[(acetyloxy)methyl]-2-methyl-4-pyridinyl]-; 34594-38-2
EINECS	Contact for details

Quality Control

Our production of 1H-Imidazo[4,5-C]Pyridine derivatives adheres to stringent quality protocols suitable for pharmaceutical R&D. Each batch undergoes comprehensive analytical characterization to ensure identity, purity, and consistency. Certificates of Analysis (COA) are provided, detailing results from HPLC, NMR, and mass spectrometry. We support cGMP-compliant manufacturing upon request to meet the exacting standards of preclinical and clinical development phases.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound may be hygroscopic (moisture-sensitive); ensure containers are sealed under an inert atmosphere after opening to maintain stability and prevent degradation.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.